Paper Publications

[31]13. Xian Y, Xu H, Gao Y, Yan J, Lv J, Ren W, Huang Q, Jiang Z, Xu F, Yao B, Weng J*. A pilot study of preproinsulin peptides reactivity in Chinese patients with type 1 diabetes. Diabetes Metab Res Rev. 2020 Feb;36(2):e3228. https://doi/10.1002/dmrr.3228..2021,
[32]15. Weng J*, Zhao J, Zhou Z, Guo X, Zou D, Ji Q, Tong N, Li Q, Zhu J, Li Q, Qin G, Feng P, Yang L, Gao Z, Chen L, Li H, Li Y, Zeng L, Zhu D, Lu J, Luo T, Cui N. Observational study evaluating the effectiveness of physician-targeted education for improving glycemic management of patients with type 2 diabetes (BEYOND II). J Diabetes. 2020 Jan;12(1):66-76. https://doi.org/10.1111/1753-0407.12963..2021,
[33]12. Xu F, Cao H, Chen Z, Gu H, Guo W, Lin B, Weng J*. Short-term GLP-1 receptor agonist exenatide ameliorates intramyocellular lipid deposition without weight loss in ob/ob mice. Int J Obes (Lond). 2020 Apr;44(4):937-947. https://doi.org/10.1038/s41366-019-0513-y..2021,
[34]11. Yang D, Yan J, Deng H, Yang X, Luo S, Zheng X, Lv J, Liang W, Hong M, Wu Z, Yao B, Weng J*, Xu W*. Effects of Metformin Added to Insulin in Adolescents with Type 1 Diabetes: An Exploratory Crossover Randomized Trial. J Diabetes Res. 2020 Dec 24;2020:7419345. https://doi.org/10.1155/2020/7419345..2021,
[35]36. Xu W, Mu Y, Zhao J, Zhu D, Ji Q, Zhou Z, Yao B, Mao A, Engel SS, Zhao B, Bi Y, Zeng L, Ran X, Lu J, Ji L, Yang W, Jia W, Weng J*. Efficacy and safety of metformin and sitagliptin based triple antihyperglycemic therapy (STRATEGY): a multicenter, randomized, controlled, non-inferiority clinical trial. Sci China Life Sci. 2017 Mar;60(3):225-238. https://doi.org/10.1007/s11427-016-0409-7..2021,
[36]28. Pan W, Zhang K, Li H, Wu M, Weng J*. Older adults are prioritized in terms of waiting time under the emergency triage system in Guangzhou, China. Geriatr Gerontol Int. 2019 Aug;19(8):786-791. https://doi.org/10.1111/ggi.13714..2021,
[37]35. Zeng K, Tian L, Sirek A, Shao W, Liu L, Chiang YT, Chernoff J, Ng DS, Weng J*, Jin T*. Pak1 mediates the stimulatory effect of insulin and curcumin on hepatic ChREBP expression. J Mol Cell Biol. 2017 Oct 1;9(5):384-394.https://doi.org/10.1093/jmcb/mjx031..2021,
[38]27. Wu Z, Jin T, Weng J*. A thorough analysis of diabetes research in China from 1995 to 2015: current scenario and future scope. Sci China Life Sci. 2019 Jan;62(1):46-62. https://doi.org/10.1007/s11427-018-9377-y..2021,
[39]10. Yang D, Zhou Y, Luo S, Zheng X, Ling P, Qiu L, Xu W, Liang H, Yao B, Weng J*,Yan J*. Clinical Characteristics of Fulminant Type 1 Diabetes Compared with Typical Type 1 Diabetes: One-Year Follow-Up Study from the Guangdong T1DM Translational Medicine Study. J Diabetes Res. 2020 Feb 19;2020:8726268. https://doi.org/10.1155/2020/8726268..2021,
[40]9. Zheng XY, Luo SH, Sun Y, Han MF, Liu J, Sun LY,Zhang LM,Ling P,Ding Y,Jin TC,Liu ZR,Weng JP*. Asymptomatic patients and asymptomatic phases of Coronavirus Disease 2019 (COVID-19): a population-based surveillance study. Natl Sci Rev.2020;7(10):1527-39. https://doi.org/10.1093/nsr/nwaa141..2021,

total52 4/6

first previous next last Page

翁建平